Opportunity Information: Apply for HRSA 20 076
The FY 2020 Rapid Antiretroviral Therapy (ART) Start in the Ryan White HIV/AIDS Program (RWHAP) - Dissemination Assistance Provider grant (HRSA-20-076) is a 3-year discretionary grant from the U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA), focused on speeding up access to HIV treatment by spreading practical, real-world models that help clinics start ART quickly after diagnosis. Rather than funding multiple direct service sites, this opportunity funds one organization to act as a national dissemination assistance provider, meaning the awardee’s primary job is to gather, analyze, package, and share effective rapid ART approaches so that other RWHAP-funded programs and HIV providers can replicate them.
At the center of the project is the development of a compendium of promising rapid ART interventions. The funded organization is expected to systematically find innovative rapid-start practices, document how they work in detail, and translate those findings into products and guidance that other providers can use. HRSA’s intent is broad and practical: identify what is working, understand the policy and operational conditions that make it work, highlight common barriers, and help other systems adapt these approaches to their own settings. The population emphasis is people with HIV who are newly diagnosed and those who are not currently engaged in care, with an overarching goal of shortening the time from diagnosis to treatment initiation and improving downstream outcomes like retention and viral suppression.
The work described in the notice includes five major activity areas. First, the recipient must conduct a comprehensive environmental scan to compile effective rapid ART interventions, essentially mapping the field and collecting models that have demonstrated results. Second, the recipient must examine policies and operational procedures that shape rapid ART start at both the clinic level and across wider systems, since rapid-start success often depends on eligibility rules, workflow design, data sharing, medication access pathways, staffing patterns, and coordination across agencies. Third, the recipient must document and disseminate what is learned, including not just success stories but also the barriers and challenges sites encounter, which can include issues like same-day medication access, insurance and Ryan White eligibility determination, lab and pharmacy logistics, and maintaining engagement after the first visit. Fourth, the recipient must assess adaptability, meaning they should help others understand which parts of a model are essential versus flexible, and how an intervention might be modified for different clinic sizes, patient populations, or local resource constraints. Fifth, the recipient must actively promote replication of effective models among RWHAP providers and other organizations serving people with HIV, shifting the project from passive reporting to active support for spread and uptake.
HRSA provides examples of the kinds of rapid ART models and interventions that fit the purpose of the grant. These include approaches proven to reduce the time from HIV diagnosis to entry into care and initiation of ART, including models that speed up eligibility determination for RWHAP services. They also include interventions that show improved retention in care, recognizing that rapid initiation alone is not enough if patients are not supported to stay connected over time. Finally, HRSA highlights interventions that demonstrate a reduced time from rapid ART initiation to viral suppression, along with sustained virologic response, aligning the program with clinical and public health goals such as durable viral suppression and reduced HIV transmission risk.
From a funding and administrative standpoint, the opportunity is a grant (not a contract) with an expected single award. The award ceiling is $1,000,000, and HRSA anticipates making one award total, reinforcing that the selected organization will serve as the central hub for this national dissemination and technical assistance-style function. The program falls under the health funding activity category and is associated with CFDA number 93.928 (RWHAP). The opportunity was posted with a creation date of November 15, 2019, and an original closing date of March 3, 2020. Eligibility is listed broadly as "Others," with applicants directed to the opportunity’s eligibility clarification section for specifics, which typically signals HRSA is open to a range of organizational types that can credibly execute national-level scanning, analysis, and dissemination work.
Overall, this grant is designed to accelerate the field’s ability to implement rapid ART start by capturing proven or promising strategies, examining the real policy and workflow conditions behind them, and turning that knowledge into practical dissemination that helps more clinics adopt models that get people from diagnosis to treatment faster, keep them engaged, and reach viral suppression sooner and more reliably.Apply for HRSA 20 076
- The Department of Health and Human Services, Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "Rapid Antiretroviral Therapy (ART) Start in the Ryan White HIV/AIDS Program – Dissemination Assistance Provider" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.928.
- This funding opportunity was created on Nov 15, 2019.
- Applicants must submit their applications by Mar 03, 2020. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the FY 2020 Rapid Antiretroviral Therapy (ART) Start in the Ryan White HIV/AIDS Program (RWHAP) - Dissemination Assistance Provider grant (HRSA-20-076)?
This is a 3-year discretionary grant from the U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA). It focuses on speeding up access to HIV treatment by spreading practical, real-world models that help clinics start antiretroviral therapy (ART) quickly after diagnosis.
What is the main purpose of this grant?
The main purpose is to accelerate rapid ART start across the field by identifying approaches that work, analyzing how and why they work (including the policy and operational conditions behind them), and packaging that knowledge into usable products and guidance so that other providers can replicate or adapt effective models.
Is this funding meant to pay for direct HIV clinical services at multiple sites?
No. The opportunity is not designed to fund multiple direct service sites. It is intended to fund one organization to serve as a national dissemination assistance provider whose primary role is to gather, analyze, package, and share effective rapid ART approaches.
How many awards does HRSA expect to make under this opportunity?
HRSA anticipates a single award. The notice describes the awardee as the central national hub for dissemination and replication support.
What is the maximum funding amount (award ceiling)?
The award ceiling is $1,000,000.
How long is the project period?
The project period is 3 years.
Is this opportunity a grant or a contract?
This opportunity is a grant, not a contract.
What type of organization is being funded?
The funded organization is expected to function as a national dissemination assistance provider. This means acting as a central entity that identifies promising rapid ART practices, documents them in detail, and shares tools, guidance, and other products that help other RWHAP-funded programs and HIV providers replicate those approaches.
What is meant by "dissemination assistance provider" in this grant?
In this context, a dissemination assistance provider is an organization whose main job is to systematically find effective rapid ART interventions, examine the conditions that support them, translate findings into practical materials, and actively promote replication among RWHAP providers and other HIV-serving organizations.
What is the compendium of promising rapid ART interventions?
The compendium is a core deliverable of the project. It is expected to be a structured collection of promising rapid ART interventions that the recipient identifies through systematic methods, documents in detail (how the interventions work in real settings), and translates into usable information for other clinics and systems.
What does HRSA expect the recipient to do to find promising interventions?
The recipient must conduct a comprehensive environmental scan to compile effective rapid ART interventions. This is described as mapping the field and collecting models with demonstrated results.
What are the major activity areas included in the notice?
The notice describes five major activity areas: (1) conducting a comprehensive environmental scan, (2) examining policies and operational procedures shaping rapid ART start, (3) documenting and disseminating what is learned (including barriers), (4) assessing adaptability of models for different settings, and (5) actively promoting replication of effective models among RWHAP providers and other organizations.
Why does this grant focus on policy and operational procedures?
HRSA highlights that rapid ART success often depends on policy and operational conditions beyond clinical intent, such as eligibility rules, workflow design, data sharing, medication access pathways, staffing patterns, and coordination across agencies. The recipient is expected to examine these factors so others can understand what it takes to implement rapid ART quickly and reliably.
What kinds of barriers is the recipient expected to capture and share?
The recipient is expected to document not only success stories, but also barriers and challenges sites encounter. Examples mentioned include same-day medication access, insurance and Ryan White eligibility determination, lab and pharmacy logistics, and maintaining engagement after the first visit.
What does "assess adaptability" mean in this project?
Assessing adaptability means helping other providers understand which parts of a rapid ART model are essential versus flexible, and how an intervention might be modified for different clinic sizes, patient populations, or local resource constraints.
What does HRSA mean by "actively promote replication"?
The notice indicates the project should go beyond passive reporting. The recipient is expected to actively promote uptake and replication of effective rapid ART models among RWHAP providers and other organizations serving people with HIV.
Who is the population emphasis for this grant?
The population emphasis is people with HIV who are newly diagnosed and those who are not currently engaged in care.
What outcomes is this grant trying to improve?
The overarching goal is to shorten the time from diagnosis to treatment initiation. The notice also emphasizes improving downstream outcomes such as retention in care and viral suppression.
What types of rapid ART models does HRSA say fit the purpose of this grant?
HRSA provides examples including: (1) approaches proven to reduce the time from HIV diagnosis to entry into care and ART initiation (including models that speed eligibility determination for RWHAP services), (2) interventions that improve retention in care, and (3) interventions that reduce the time from rapid ART initiation to viral suppression and support sustained virologic response.
Does HRSA emphasize retention in care as part of rapid ART work?
Yes. HRSA explicitly notes that rapid initiation alone is not enough if patients are not supported to stay connected over time, and highlights models that show improved retention in care.
How does viral suppression relate to the goals of this opportunity?
HRSA highlights interventions that reduce time to viral suppression and support sustained virologic response. This aligns the grant with clinical and public health goals such as durable viral suppression and reduced HIV transmission risk.
What is the CFDA number associated with this opportunity?
The opportunity is associated with CFDA number 93.928 (Ryan White HIV/AIDS Program).
What funding activity category does this opportunity fall under?
The opportunity falls under the health funding activity category.
When was this opportunity posted and when did it close?
The notice lists a creation (posting) date of November 15, 2019, and an original closing date of March 3, 2020.
Who is eligible to apply based on the notice?
Eligibility is listed broadly as "Others," and applicants are directed to the eligibility clarification section for specifics. This typically signals HRSA may be open to a range of organizational types that can credibly execute national-level scanning, analysis, and dissemination work.
What is the practical difference between this grant and funding for clinics?
Rather than primarily paying for clinic operations or direct patient care, this grant is designed to capture and spread what works across many settings. The funded organization serves as a national hub that produces a compendium and other dissemination products and supports replication so more clinics can implement rapid ART start effectively.
Browse more opportunities from the same category: Health
Next opportunity: EXAMPLE
Previous opportunity: State and Local Government Data Analysis Tools for Roadway Safety
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HRSA 20 076
Applicants also applied for:
Applicants who have applied for this opportunity (HRSA 20 076) also looked into and applied for these:
| Funding Opportunity |
|---|
| Rural Health Research Center Program Apply for HRSA 20 035 Funding Number: HRSA 20 035 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $700,000 |
| Ryan White HIV/AIDS Program - Data Integration, Systems, and Quality Technical Assistance Apply for HRSA 20 070 Funding Number: HRSA 20 070 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $800,000 |
| Ryan White HIV/AIDS Program - TargetHIV Apply for HRSA 20 094 Funding Number: HRSA 20 094 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $700,000 |
| Early Psychosis Intervention Network (EPINET): Practice-Based Research to Improve Treatment Outcomes (R01 Clinical Trial Optional) Apply for RFA MH 20 205 Funding Number: RFA MH 20 205 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Strengthening Multi-sectoral Coordination and Implementation and Monitoring of HIV/AIDS in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2052 Funding Number: CDC RFA GH20 2052 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Achieving and Maintaining Epidemic Control through Comprehensive HIV/AIDS Prevention, Care and Treatment Services in the Kinshasa Region of the Democratic Republic of Congo under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2023 Funding Number: CDC RFA GH20 2023 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $5,000,000 |
| Clinical Trials Planning for Symptomatic Vascular Contributions to Cognitive Impairment and Dementia (VCID) (R34 Clinical Trial Not Allowed) Apply for RFA NS 20 012 Funding Number: RFA NS 20 012 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $150,000 |
| 2020 Integrated Networks to Deliver and Sustain Evidence-Based Chronic Disease Self-Management Education Programs Apply for HHS 2020 ACL AOA CSSG 0366 Funding Number: HHS 2020 ACL AOA CSSG 0366 Agency: Department of Health and Human Services, Administration for Community Living Category: Health Funding Amount: $1,500,000 |
| 2020 Empowering Communities to Address Behavioral Health and Chronic Pain through Chronic Disease Self-Management Education Programs Apply for HHS 2020 ACL AOA CSSG 0365 Funding Number: HHS 2020 ACL AOA CSSG 0365 Agency: Department of Health and Human Services, Administration for Community Living Category: Health Funding Amount: $300,000 |
| 2020 Integrated Networks to Deliver and Sustain Evidence-Based Falls Prevention Programs Apply for HHS 2020 ACL AOA FPSG 0367 Funding Number: HHS 2020 ACL AOA FPSG 0367 Agency: Department of Health and Human Services, Administration for Community Living Category: Health Funding Amount: $1,200,000 |
| 2020 Empowering Communities to Reduce Falls and Falls Risk Apply for HHS 2020 ACL AOA FPSG 0372 Funding Number: HHS 2020 ACL AOA FPSG 0372 Agency: Department of Health and Human Services, Administration for Community Living Category: Health Funding Amount: $300,000 |
| Assisted Outpatient Treatment Program for Individuals with Serious Mental Illness Apply for SM 20 006 Funding Number: SM 20 006 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $1,000,000 |
| Evaluating Practice-based Programs, Policies, and Practices from CDCs Rape Prevention and Education (RPE) Program: Expanding the Evidence to Prevent Sexual Violence Apply for RFA CE 20 001 Funding Number: RFA CE 20 001 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $375,000 |
| Laboratories to Optimize Digital Health (R01 Clinical Trial Required) Apply for RFA MH 20 510 Funding Number: RFA MH 20 510 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Safety and Feasibility Trials for Rapid-Acting Interventions for Severe Suicide Risk (R01 Clinical Trial Required) Apply for RFA MH 20 345 Funding Number: RFA MH 20 345 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $400,000 |
| National Health Technical Assistance Program (NHTAP) Apply for 72030620FRA00004 Funding Number: 72030620FRA00004 Agency: Agency for International Development, Afghanistan USAID-Kabul Category: Health Funding Amount: $117,000,000 |
| Urban Health Initiative (UHI) Apply for 72030620RFA00005 Funding Number: 72030620RFA00005 Agency: Agency for International Development, Afghanistan USAID-Kabul Category: Health Funding Amount: $104,000,000 |
| National Health Technical Assistance Program (NHTAP) Apply for 72030620RFA00004 Funding Number: 72030620RFA00004 Agency: Agency for International Development, Afghanistan USAID-Kabul Category: Health Funding Amount: $117,000,000 |
| Implementation of Sustainable Laboratory Quality Systems for HIV/TB Epidemic Control in the Republic of Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2039 Funding Number: CDC RFA GH20 2039 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Improving Prevention, Treatment, and Care Services for HIV, TB, and Other Infectious Diseases in Target Populations in the Dominican Republic under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2020 Funding Number: CDC RFA GH20 2020 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 20 076", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.